Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon L Walmsley

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|June 29, 2025
CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a canadian cohort of people aged 65 and older living with HIVJulian J Hopwood-Raja, Alice L Tseng, Nancy L Sheehan, et al.
Clinical & Translational Immunology|April 20, 2026
Neutralising antibody responses to emerging SARS-CoV-2 omicron sub-variants are enhanced in persons with hybrid immunitySharon L Walmsley, Majid Nabipoor, Freda Qi, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2020
Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelinesAlice Zhabokritsky, Leah Szadkowski, Curtis Cooper, et al.
The Journal of Infectious Diseases|October 17, 2024
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C CoinfectionEsther Truscello, Shouao Wang, Jim Young, et al.
Open Forum Infectious Diseases|September 18, 2015
Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central AdiposityJordan E Lake, Grace A McComsey, Todd Hulgan, et al.
Sexually Transmitted Diseases|December 23, 2008
Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in CanadaBarbara Romanowski, Linda N Myziuk, Sharon L Walmsley, et al.
Journal of the International AIDS Society|September 29, 2022
"We can hardly even do it nowadays. So, what's going to happen in 5 years from now, 10 years from now?" The health and community care and support needs and preferences of older people living with HIV in Ontario, Canada: a qualitative studyKate Murzin, Elizabeth Racz, D M Behrens, et al.
BMJ Open|November 3, 2019
Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, CanadaAndrew David Eaton, Sharon L Walmsley, Shelley L Craig, et al.
AIDS (London, England)|December 20, 2007
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scoresSharon L Walmsley, Laurent Cotte, Stefano Rusconi, et al.
HIV Clinical Trials|December 14, 2016
Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot studyDarrell H S Tan, Janet Raboud, Leah Szadkowski, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|June 29, 2025
CHANGE-Rx: frailty, falls, polypharmacy, and inappropriate medication use in a canadian cohort of people aged 65 and older living with HIVJulian J Hopwood-Raja, Alice L Tseng, Nancy L Sheehan, et al.
Clinical & Translational Immunology|April 20, 2026
Neutralising antibody responses to emerging SARS-CoV-2 omicron sub-variants are enhanced in persons with hybrid immunitySharon L Walmsley, Majid Nabipoor, Freda Qi, et al.
The Journal of Antimicrobial Chemotherapy|November 29, 2020
Increased CD4 : CD8 ratio normalization with implementation of current ART management guidelinesAlice Zhabokritsky, Leah Szadkowski, Curtis Cooper, et al.
The Journal of Infectious Diseases|October 17, 2024
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C CoinfectionEsther Truscello, Shouao Wang, Jim Young, et al.
Open Forum Infectious Diseases|September 18, 2015
Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central AdiposityJordan E Lake, Grace A McComsey, Todd Hulgan, et al.
Sexually Transmitted Diseases|December 23, 2008
Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in CanadaBarbara Romanowski, Linda N Myziuk, Sharon L Walmsley, et al.
Journal of the International AIDS Society|September 29, 2022
"We can hardly even do it nowadays. So, what's going to happen in 5 years from now, 10 years from now?" The health and community care and support needs and preferences of older people living with HIV in Ontario, Canada: a qualitative studyKate Murzin, Elizabeth Racz, D M Behrens, et al.
BMJ Open|November 3, 2019
Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, CanadaAndrew David Eaton, Sharon L Walmsley, Shelley L Craig, et al.
AIDS (London, England)|December 20, 2007
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scoresSharon L Walmsley, Laurent Cotte, Stefano Rusconi, et al.
HIV Clinical Trials|December 14, 2016
Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot studyDarrell H S Tan, Janet Raboud, Leah Szadkowski, et al.
Pageof 11